1, 4, 8-Triazaphenanthrene Derivatives For The Treatment Of Neurodegenerative Disorders
申请人:Institut Du Cerveau et de la Moëlle Epiniere
公开号:US20190071438A1
公开(公告)日:2019-03-07
The invention relates to compounds of formula (I), particularly for the use thereof as a medicament, especially in the treatment or prevention of neurogenerative disorders. The invention also relates to the methods for producing said compounds, and to the pharmaceutical compositions containing same.
该发明涉及公式(I)的化合物,特别是其作为药物的用途,特别是用于治疗或预防神经退行性疾病。该发明还涉及制备所述化合物的方法,以及含有相同化合物的药物组合物。